OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Effectiveness and durability of mRNA-1273 BA.4/BA.5 bivalent vaccine (mRNA-1273.222) against SARS-CoV-2 BA.4/BA.5 and XBB sublineages
Bradley K. Ackerson, Katia Bruxvoort, Lei Qian, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 7
Bradley K. Ackerson, Katia Bruxvoort, Lei Qian, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 7
Showing 7 citing articles:
Morris responds to “Critical analyses concerning COVID-19 vaccines need to be consistently critical, and informed”
Jeffrey S. Morris
American Journal of Epidemiology (2025)
Closed Access
Jeffrey S. Morris
American Journal of Epidemiology (2025)
Closed Access
Durability of immune responses to SARS-CoV-2 infection and vaccination
Mehul S. Suthar
Seminars in Immunology (2024) Vol. 73, pp. 101884-101884
Closed Access | Times Cited: 4
Mehul S. Suthar
Seminars in Immunology (2024) Vol. 73, pp. 101884-101884
Closed Access | Times Cited: 4
Protection of vaccine boosters and prior infection against mild/asymptomatic and moderate COVID-19 infection in the UK SIREN healthcare worker cohort: October 2023 to March 2024
Peter Kirwan, Sarah Foulkes, Katie Munro, et al.
Journal of Infection (2024) Vol. 89, Iss. 5, pp. 106293-106293
Open Access | Times Cited: 2
Peter Kirwan, Sarah Foulkes, Katie Munro, et al.
Journal of Infection (2024) Vol. 89, Iss. 5, pp. 106293-106293
Open Access | Times Cited: 2
Post-vaccination, post-infection and hybrid immunity against severe cases of COVID-19 and long COVID after infection with SARS-CoV-2 Omicron subvariants, Czechia, December 2021 to August 2023
Martin Šmíd, Tamara Barusová, Jiří Jarkovský, et al.
Eurosurveillance (2024) Vol. 29, Iss. 35
Open Access | Times Cited: 1
Martin Šmíd, Tamara Barusová, Jiří Jarkovský, et al.
Eurosurveillance (2024) Vol. 29, Iss. 35
Open Access | Times Cited: 1
A descriptive review on the real-world impact of Moderna, inc. COVID-19 vaccines
Mary T. Bausch-Jurken, Rachel Dawson, Francesca Ceddia, et al.
Expert Review of Vaccines (2024)
Open Access
Mary T. Bausch-Jurken, Rachel Dawson, Francesca Ceddia, et al.
Expert Review of Vaccines (2024)
Open Access
Methodology of comparative studies on the relative effectiveness of COVID-19 vaccines: a systematic review
Erdenetuya Bolormaa, Ji Ae Shim, Young-Sook Choi, et al.
Osong Public Health and Research Perspectives (2024) Vol. 15, Iss. 5, pp. 395-408
Open Access
Erdenetuya Bolormaa, Ji Ae Shim, Young-Sook Choi, et al.
Osong Public Health and Research Perspectives (2024) Vol. 15, Iss. 5, pp. 395-408
Open Access
Effectiveness of mRNA COVID-19 vaccines and hybrid immunity in preventing SARS-CoV-2 infection and symptomatic COVID-19 among adults in the United States
Leora R. Feldstein, Jasmine Ruffin, Ryan E. Wiegand, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Leora R. Feldstein, Jasmine Ruffin, Ryan E. Wiegand, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
